Cargando…
Monocyte anisocytosis increases during multisystem inflammatory syndrome in children with cardiovascular complications
BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening complication that can develop weeks to months after an initial SARS-CoV-2 infection. A complex, time-consuming laboratory evaluation is currently required to distinguish MIS-C from other illnesses. New assays are...
Autores principales: | Yonker, Lael M., Badaki-Makun, Oluwakemi, Arya, Puneeta, Boribong, Brittany P., Moraru, Gabriela, Fenner, Brittany, Rincon, Jaimar, Hopke, Alex, Rogers, Brent, Hinson, Jeremiah, Fasano, Alessio, Lee, Lilly, Kehoe, Sarah M., Larson, Shawn D., Chavez, Hector, Levin, Scott, Moldawer, Lyle L., Irimia, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208352/ https://www.ncbi.nlm.nih.gov/pubmed/35725405 http://dx.doi.org/10.1186/s12879-022-07526-9 |
Ejemplares similares
-
Correction to: Monocyte anisocytosis increases during multisystem inflammatory syndrome in children with cardiovascular complications
por: Yonker, Lael M., et al.
Publicado: (2022) -
Monocyte anisocytosis corresponds with increasing severity of COVID-19 in children
por: Kane, Abigail S., et al.
Publicado: (2023) -
The Heart of the Problem in Multisystem Inflammatory Syndrome in Children
por: Boribong, Brittany P., et al.
Publicado: (2021) -
Zonulin Antagonist, Larazotide (AT1001), As an Adjuvant Treatment for Multisystem Inflammatory Syndrome in Children: A Case Series
por: Yonker, Lael M., et al.
Publicado: (2022) -
Heterogeneity in the evaluation of suspected MIS-C: a cross-sectional vignette-based survey
por: Rosu, Claudia A., et al.
Publicado: (2022)